RBM-005

N/A

Report date: 2023/05/22 10:16:35
NME

Base Information

Drug NameRBM-005
Drug Alias Nameanti-HMGB1 aptamer(Ribomic Inc)RBM005
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionHigh Mobility Group Proteins inhibitors
TargetsHigh Mobility Group Proteins
Therapy Area/IndicationsFibrosisSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRibomic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRibomic
Active IndicationsN/A
Inactive IndicationsFibrosisSepsis

Other Information

ATC CodeN/A
Related LinksN/A